Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of the EF192B Protection Versus No Treatment
Sponsor: Eurofarma Laboratorios S.A.
Summary
This study was designed with the objective of evaluating the protection potential provided by the experimental product EF192B by evaluating its barrier formation capacity. Once its ability to form a barrier is confirmed, EF192B ability to protect against small skin injuries, such as small cuts, bruises, blisters and cracks is confirmed. The barrier formation also guarantees protection against the formation of calluses.
Official title: Randomized, Open Clinical Study to Evaluate the Protective Potential of EF192B Versus No Treatment
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
72
Start Date
2025-08-31
Completion Date
2025-10-31
Last Updated
2024-12-30
Healthy Volunteers
Yes
Conditions
Interventions
EF192B
EF192B will be applied after the tape strriping procedure and will be reapplied after 12 hours.
Locations (1)
Eurofarma Laboratórios S.A
Itapevi, São Paulo, Brazil